Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PsychoGenics
PsychoGenics
Sunovion’s SEP-363856 gets FDA breakthrough status for schizophrenia
Pharmaceutical Business Review
Tue, 05/14/19 - 09:24 am
Sunovion
PsychoGenics
breakthrough therapies
SEP-363856
schizophrenia